APA (7th ed.) Citation

Zhu, Y., Wu, W., Lin, L., Zhang, L., Cai, J., Sun, H., & Wei, X. (2026). The cost-effectiveness and budget impact of zoledronic acid as adjuvant therapy in postmenopausal women with early breast cancer. Journal of Chinese Pharmaceutical Sciences, 35(3), 292. https://doi.org/10.5246/jcps.2026.03.020

Chicago Style (17th ed.) Citation

Zhu, Yixiao, Wenhua Wu, Li Lin, Lirong Zhang, Jiaqing Cai, Hong Sun, and Xiaoxia Wei. "The Cost-effectiveness and Budget Impact of Zoledronic Acid as Adjuvant Therapy in Postmenopausal Women with Early Breast Cancer." Journal of Chinese Pharmaceutical Sciences 35, no. 3 (2026): 292. https://doi.org/10.5246/jcps.2026.03.020.

MLA (9th ed.) Citation

Zhu, Yixiao, et al. "The Cost-effectiveness and Budget Impact of Zoledronic Acid as Adjuvant Therapy in Postmenopausal Women with Early Breast Cancer." Journal of Chinese Pharmaceutical Sciences, vol. 35, no. 3, 2026, p. 292, https://doi.org/10.5246/jcps.2026.03.020.